Our objective was to determine the effects of fish oil on renal functi
on, symptoms, and serum lipids in patients with lupus nephritis. A dou
ble-blind, randomized crossover trial of fish oil versus placebo (oliv
e oil) was done on 26 patients with confirmed systemic lupus; 21 compl
eted the study. Intervention was fish oil or placebo, 15 g/day, for on
e year followed by a 10 week wash-out period, and then the reverse tre
atment for one year. At baseline and six month intervals, we measured
platelet membrane fatty acids, indices of renal function, a disease ac
tivity index, serum lipid levels, blood pressure, serum viscosity and
red cell flexibility. We found that platelet membrane phospholipids we
re uniformly affected by fish oil supplementation (P < 0.001) but with
significant carry-over effects despite a 10 week wash-out period. Glo
merular filtration rate and serum creatinine were not affected. A non-
significant reduction in mean (SE) 24-hour proteinuria occurred, from
1424.1 mg (442.7) on placebo to 896.7 mg (352.2) on fish oil (P = 0.21
). Fish oil lowered serum triglycerides from 1.89 (0.25) mmol/liter to
1.02 (0.11) mmol/liter (P = 0.004). VLDL cholesterol decreased marked
ly whether patients initially received fish oil or placebo (P = 0.004)
. The size of the reduction was affected by the order of treatment (P
= 0.03), but parallel comparisons were significant before the crossove
r (P = 0.0006). With the possible exception of bleeding time, no other
treatment effects were shown with fish oil. However, treatment order
effects were seen in urinary IgG excretion (P = 0.03), whole blood vis
cosity (P < 0.0001), red cell flexibility (P = 0.004), and bleeding ti
me (P = 0.06). In conclusion, one year of dietary supplementation with
fish oil in patients with stable lupus nephritis did not improve rena
l function or reduce disease activity, but did alter some lipid parame
ters. Hitherto unreported carry-over effects and treatment order effec
ts caused by the olive oil created a risk of type II error, and bear m
ethodologic consideration in the design of future studies.